Publications

Copies for many of the following papers can be found at the Digital Commons site for the Hage group.


2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2000-2004 1995-1999 1984-1994 Books and Chapters
2016

250.) Cong Bi, Xiwi Zheng and David S. Hage*, “Analysis of Free Drug Fractions in Serum by Ultrafast Affinity Extraction and Two-Dimensional Affinity Chromatography using Alpha1-Acid Glycoprotein Microcolumns”, J. Chromatogr. A, 1432 (2016) 49-57.

249.) Zhao Li, Sandya R. Beeram, Cong Bi, D. Suresh1, Xiwei Zheng, and David S. Hage*, “High-Performance Affinity Chromatography: Applications in Drug-Protein Binding Studies and Personalized Medicine”, Advances in Protein Chemistry and Structural Biology, Vol. 102, Rossen Donev (Ed.), 2016, Chap. 1 (pp. 1-39).

2015

248.) Xiwei Zheng, Marissa Brooks, and David S. Hage*, “Analysis of Hormone-Protein Binding in Solution by Ultrafast Affinity Extraction: Interactions of Testosterone with Human Serum Albumin and Sex Hormone Binding Globulin”, Anal. Chem, 87 (2015) 11187-11194.

247.) Ryan Matsuda, Elliott Rodriguez, D. Suresh1, and David S. Hage*, “Chromatographic Immunoassays: Strategies and Recent Developments in the Analysis of Drugs and Biological Agents”, Bioanalysis, 7 (2015) 2947-2966.

246.) Ryan Matsuda, Donald Jobe, Jared Beyersdorf, and David S. Hage*, “Analysis of Drug-Protein Binding using On-Line Immunoextraction and High-Performance Affinity Microcolumns: Studies with Normal and Glycated Human Serum Albumin”, J. Chromatogr. A, 1416 (2015) 112-120.

245.) Ryan Matsuda, Jeanethe Anguizola, Krina S Hoy, David S Hage, “Analysis of drug–protein interactions by high-performance affinity chromatography: Interactions of sulfonylurea drugs with normal and glycated human serum albumin”, Methods in molecular biology (Clifton, N.J.), 1286 (2015) 255-277.239.)

244.) David S Hage, Ryan Matsuda, “Affinity chromatography: a historical perspective.”, Methods in molecular biology (Clifton, N.J.), 1286 (2015) 1-19.

243.) Xiwei Zheng, Cong Bi, Zhao Li, Maria Podariu, David S Hage, “Analytical methods for kinetic studies of biological interactions: A review”, Journal of Pharmaceutical and Biomedical Analysis, 113 (2015) 163-180.

242.) Ryan Matsuda, Zhao Li, Xiwei Zheng, David S Hage, “Analysis of glipizide binding to normal and glycated human serum albumin by high-performance affinity chromatography”, Analytical and Bioanalytical Chemistry, 407 (2015) 5309-5321.

241.) Xiwei Zheng, Maria Podariu, Cong Bi, David S. Hage, “Development of Enhanced Capacity Affinity Microcolumns by using a Hybrid of Protein Cross-linking/Modification and Immobilization”, Journal of Chromatography A, 1400 (2015) 82-89.

240.) Ryan Matsuda, Zhao Li, Xiwei Zheng, David S Hage, ” Analysis of Multi-Site Drug-Protein Interactions by High-Performance Affinity Chromatography: Binding by Glimepiride to Normal or Glycated Human Serum Albumin” Journal of Chromatography A, 1408 (2015) 133-144.

239.) David S. Hage*, “Foreword”, In: Advances in Liquid Chromatography: New Developments in Stationary Phases and Supports for Drugs and Bioanalytical Applications, David S. Hage (Editor), Future Science, London, 2015, Foreword (pp, 2-4).

238.) Erika L. Pfaunmiller, Cong Bi, Zhao Li, John Vargas-Badilla, Xiwei Zheng and David S. Hage*, “Immunoaffinity Chromatography”, In: Advances in Liquid Chromatography: New Developments in Stationary Phases and Supports for Drugs and Bioanalytical Applications, David S. Hage (Editor), Future Science, London, 2015, Chap. 5 (pp. 60-74).

237.) Cong Bi, Sandya Beeram, Zhao Li, Xiwei Zheng, and David S. Hage*, “Kinetic Analysis of Drug-Protein Interactions by Affinity Chromatography”, Drug Discovery Today: Technologies, 17 (2015) 16-21.

236.) David S. Hage*, “Affinity Separations”, In: Chemistry, Molecular Sciences and Chemical Engineering, Jan Reedijk (Ed.), Elsevier, Amsterdam, 2015

235.) David S. Hage*, “Affinity Chromatography”, Kirk-Othmer Encyclopedia of Chemical Technology, 6th Edition, Azra Seidel (ed.), Wiley, New York, 2015.

2014

234.) Xiwei Zheng, Ryan Matsuda, David S. Hage, “Analysis of free drug fractions by ultrafast affinity extraction: Interactions of sulfonylurea drugs with normal or glycated human serum albumin”, Journal of Chromatography A, 1371 (2014) 82-89.233.) Erika L. Pfaunmiller, Jeanethe A. Anguizola, Mitchell L. Milanuk, Efthimia Papastavros, NaTasha Carter, Ryan Matsuda, Xiwei Zheng, and David S. Hage*, “Development of Microcolumn-Based One-Site Immunometric Assays for Protein Biomarkers”, J. Chromatogr. A, 1366 (2014) 92-100.

232.) Matthew R. Sobansky and David S. Hage*, “Analysis of Drug Interactions with Very Low Density Lipoprotein by High-Performance Affinity Chromatography”, Anal. Biochem. Chem., 406 (2014) 6203-6211.

231.) David S. Hage* and Ryan Matsuda, “Affinity Chromatography – A Historical Perspective”, Methods Mol. Biol., in press.

230.) Ryan Matsuda, Jeanethe Anguizola, Krina S. Hoy, and David S. Hage*, “Analysis of Drug-Protein Interactions by High-Performance Affinity Chromatography: Interactions of Sulfonylurea Drugs with Normal and Glycated Human Serum Albumin”, Methods Mol. Biol., in press.

229.) Xiwei Zheng, Zhao Li, Maria Podariu, and David S. Hage*, “Determination of Rate Constants and Equilibrium Constants for Solution-Phase Drug-Protein Interactions by Ultrafast Affinity Extraction”, Anal. Chem., 86 (2014) 6454-6460.

228.) Ryan Matsuda, Cong Bi, Jeanethe Anguizola, Matthew Sobansky, Elliot Rodriguez, John Vargas Badilla, Xiwei Zheng, Benjamin Hage and David S. Hage*, “Studies of Metabolite-Protein Interactions: A Review”, J. Chromatogr. B, 966 (2014) 48-58.

227.) Annette C. Moser, Corey W. Willicott and David S. Hage*, “Clinical Applications of Capillary Electrophoresis-Based Immunoassays”, Electrophoresis, 35 (2014) 937-955.

226.) Xiwei Zheng, Zhao Li, Sandya Beeram, Ryan Matsuda, Erika L. Pfaunmiller, Maria Podariu, Christopher J. White II, NaTasha Carter, and David S. Hage*, “Analysis of Biomolecular Interactions using Affinity Microcolumns: A Review”, J. Chromatogr. B, 968 (2014) 49-63.

225.) David S. Hage*, “Affinity Chromatography”, Kirk-Othmer Encyclopedia of Chemical Technology, 6th Edition, Azra Seidel (ed.), Wiley, in press.

225.) David S. Hage*, “Foreword”, In: Chromatographic Stationary Phases: Recent Advances and Novel Applications, Naila Zaman (Editor), Future Science, London, in press.

224.) Erika L. Pfaunmiller, Cong Bi, Zhao Li, John Vargas-Badilla, Xiwei Zheng and David S. Hage*, “Immunoaffinity Chromatography”, In: Chromatographic Stationary Phases: Recent Advances and Novel Applications, Naila Zaman (Editor), Future Science, London, in press.

223.) Ryan Matsuda, So-Hwang Kye, Jeanethe Anguizola, and David S. Hage*, “Studies of Drug Interactions with Glycated Human Serum Albumin by High-Performance Affinity Chromatography”, Rev. Anal. Chem., 33 (2014) 79-94.

2013

222.) David S. Hage*, “An Overview of CE in Clinical Analysis”, In: Clinical Applications of Capillary Electrophoresis, T. M. Phillips (Editor), Humana, Totowa, NJ, 2013, Chapter 1.

221.) David S. Hage*, Jeanethe A. Anguizola, Rong Li, Ryan Matsuda, Efthimia Papastavros, Erika Pfaunmiller, Matthew Sobansky, and Xiwei Zheng, “Affinity Chromatography”, In: Liquid Chromatography: Applications, S. Fanali, P.R. Haddad, C.F. Poole, P. Schoenmakers and D. Lloyd, editors, Elsevier, Amsterdam, Chap. 1, 2013.

220.) Erika L. Pfaunmiller, Marie Laura Paulemond, Courtney M. Dupper, and David S. Hage*, “Affinity Monolith Chromatography: A Review of Principles and Recent Analytical Applications”, Anal. Bioanal. Chem., 405 (2013) 2133-2145.

219.) Jeanethe Anguizola, K.S. Joseph, Omar S. Barnaby, Ryan Matsuda, Guadalupe Alvarado, William Clark, Ronald L. Cerny, and David S. Hage*, “Development of Affinity Microcolumns for Drug-Protein Binding Studies in Personalized Medicine: Interactions of Sulfonylurea Drugs with in vivo Glycated Human Serum Albumin”, Anal.  Chem., 85 (2013) 4453-4460.

218.) Abby J. Jackson, Jeanethe Anguizola, Erika L. Pfaunmiller, and David S. Hage*, “Use of Entrapment and High-Performance Affinity Chromatography to Compare the Binding of Drugs and Site-Specific Probes with Normal and Glycated Human Serum Albumin”, Anal. Bioanal. Chem., 405 (2013) 5833-5841.

217.) Jeanethe Anguizola, Ryan Matsuda, Omar S. Barnaby, K.S. Hoy, Chunling Wa, Erin Debolt, Michelle Koke and David S. Hage*, “Review: Glycation of Human Serum Albumin”, Clin. Chim. Acta, 425 (2013) 64-76.

216.) David S. Hage*, “Affinity Chromatography”, In: Chemical, Molecular Sciences and Engineering – online reference database, Jan Reedijk (Editor-in-Chief), Elsevier, Amsterdam, Chap. 283, 2013.

215.) Efthimia Papastavros, Cong Bi, Erika L. Pfaunmiller and David S. Hage*, “Liquid Chromatographic Techniques for Bioanalysis: Recent Trends and Developments”, In: Bioanalysis for Service Users, Anne-Francoise Aubry, Patrick Bennett, David Hage, Howard Hill, Marian Kelley, Yan Ni, and Leif Svensson (Editors), Future Science, London, 2013, Chapter 4.

214.)  Xiwei Zheng, Michelle J. Yoo and David S. Hage*, “Analysis of Free Fractions for Chiral Drugs using Ultrafast Extraction and Multi-Dimensional High-Performance Affinity Chromatography”, Analyst, 138 (2013) 6262-6265.

213.) Jeanethe A. Anguizola, Sara B. G. Basiaga and David S. Hage*, “Effects of Fatty Acids and Glycation on Drug Interactions with Human Serum Albumin”, Curr. Metabolomics, 1 (2013) 239-250.

212.) David S. Hage*, “Affinity Chromatography” in:  Elsevier Reference Module in Chemistry, Molecular Sciences and Chemical Engineering, J. Reedijk (Ed.), Elsevier, Waltham, MA, 2013. doi: 10.1016/B978-0-12-409547-2.00283-3.

2012

211.) Matthew R. Sobansky and David S. Hage*, “Identification and Analysis of Stereoselective Drug Interactions with Low Density Lipoprotein by High-Performance Affinity Chromatography”, Anal. Biochem. Chem., 403 (2012) 563-571.

210.) E. Pfaunmiller, Annette C. Moser and David S. Hage*, “Biointeraction Analysis of Immobilized Antibodies and Related Agents by High-Performance Immunoaffinity Chromatography”, Methods, 56 (2012) 130-135.

209.) Abby J. Jackson, Matthew R. Sobansky and David S. Hage*, “Principles and Applications of Immunoaffinity Chromatography”, In: Antibodies, Eline P. Meulenberg (Ed.), Bentham, Netherlands, 2012, Chapter 10.

208.) Matthew R. Sobansky and David S. Hage*, “Analysis of Drug Interactions with Lipoproteins by High-Performance Affinity Chromatography”, In: Advances in Medicine and Biology, Vol. 53, L.V. Berhardt (ed.), Nova Science Publishers, 2012, Chapter 9.

207.) David S. Hage*, Jeanethe A. Anguizola, Cong Bi, Rong Li, Ryan Matsuda, Efthimia Papastavros, Erika Pfaunmiller, John Vargas and Xiwei Zheng, “Pharmaceutical and Biomedical Applications of Affinity Chromatography: Recent Trends and Developments”, J. Pharm. Biomed. Anal., 69 (2012) 93-105.

206.) David S. Hage*, “Affinity Chromatography”, In: Encyclopedia of Analytical Chemistry: Instrumentation and Applications, 2nd ed., R. A. Meyers (Editor-in-chief), Wiley, New York, On-line article, 2012.

205.) Erika L. Pfaunmiller, Mahli Hartmann, Courtney M. Dupper, Sony Soman and David S. Hage*, “Optimization of Human Serum Albumin Monoliths for Chiral Separations and High-Performance Affinity Chromatography”, J. Chromatogr. A, 1269 (2012) 198-207.

204.) Ryan Matsuda, Jeanethe Anguizola, K.S. Joseph and David S. Hage*, “Analysis of Drug Interactions with Modified Proteins by High-Performance Affinity Chromatography: Binding of Glibenclamide to Normal and Glycated Human Serum Albumin”, J. Chromatogr. A, 1265 (2012) 114-122.

2011

203.) K.S. Joseph, Jeanethe Anguizola and David S. Hage*, “Binding of Tolbutamide to Glycated Human Serum Albumin”, J. Pharm. Biomed. Anal., 54 (2011) 426-432.202.) David S. Hage*, Jeanethe Anguizola, Omar Barnaby, Abby Jackson, Michelle J. Yoo, Efthimia Papastavros, Erika Pfaunmiller, Matthew Sobansky, Zenghan Tong, “Characterization of Drug Interactions with Serum Proteins by Using High-Performance Affinity Chromatography”, Curr. Drug Metabolism, 12 (2011) 313-328.201.) Michelle J. Yoo and David S. Hage*, “Use of Peak Decay Analysis and Affinity Microcolumns Containing Silica Monoliths for Rapid Determination of Drug-Protein Dissociation Rates”, J. Chromatogr. A, 1218 (2011) 2072-2078.

200.) Zenghan Tong, John E. Schiel, Efthimia Papastavros, Corey M. Ohnmacht, Quentin R. Smith and David S. Hage*, “Kinetic Studies of Drug-Protein Interactions by Using Peak Profiling and High-Performance Affinity Chromatography: Examination of Multi-site Interactions of Drugs with Human Serum Albumin Columns”, J. Chromatogr. A, 1218 (2011) 2065-2071.

199.) Omar S. Barnaby, Ronald L. Cerny, William Clarke, and David S. Hage*, “Comparison of Modification Sites Formed on Human Serum Albumin at Various Stages of Glycation”, Clin. Chim. Acta, 412 (2011) 277-285.

198.) David S. Hage*, Eric D. Dodds, Liangcheng Du and Robert Powers, “Research in Bioanalysis and Separations at the University of Nebraska-Lincoln”, Bioanalysis, 3 (2011) 1065-1076.

197.) David S. Hage*, Jeanethe A. Anguizola, Abby J. Jackson, Ryan Matsuda, Efthimia Papastavros, Erika Pfaunmiller, Zenghan Tong, John Vargas-Badilla, Michelle J. Yoo, and Xiwei Zheng, “Chromatographic Analysis of Drug Interactions in the Serum Proteome”, Anal. Methods, 3 (2011) 1449-1460.

196.) Michelle J. Yoo and David S. Hage*, “High-Throughput Analysis of Drug Dissociation from Serum Proteins Using Affinity Silica Monoliths”, J. Sep. Sci., 34 (2011) 2255-2263.

195.) Omar S. Barnaby, Ronald L. Cerny, William Clarke, and David S. Hage*, “Quantitative Analysis of Glycation Patterns in Human Serum Albumin Using 16O/18O-Labeling and MALDI-TOF MS”, Clin. Chim. Acta, 412 (2011) 1606-1615.

194.) Zenghan Tong and David S. Hage*, “Characterization of Interaction Kinetics Between Chiral Solutes and Human Serum Albumin by Using High-Performance Affinity Chromatography and Peak Profiling”, J. Chromatogr. A, 1218 (2011) 6892-6897.

193.) Ryan Matsuda, Jeanethe Anguizola, K.S. Joseph and David S. Hage*, “High-Performance Affinity Chromatography and the Analysis of Drug Interactions with Modified Proteins: Binding of Gliclazide with Glycated Human Serum Albumin”, Anal. Bioanal. Chem., 401 (2011) 2811-2819.

192.) David S. Hage*, Efthimia Papastavros, Daniel D. Snow, “High-Performance Immunosorbents for the Selective Trace Analysis of Emerging Contaminants in Water”, Proc. Water Environ Fed., 2010 Meeting (2011) 5794-5806.

191.) Zenghan Tong and David S. Hage*, “Detection of Heterogeneous Drug-Protein Binding by Frontal Analysis and High-Performance Affinity Chromatography and Peak Profiling”, J. Chromatogr. A, 1218 (2011) 8915-8924.

190.) John E. Schiel, Zenghan Tong, Chainarong Sakulthaew and David S. Hage*, “Development of a Flow-Based Ultrafast Immunoextraction and Reverse Displacement Immunoassay: Analysis of Free Drug Fractions”, Anal. Chem., 83 (2011) 9384-9390.

189.) David S. Hage*, “Chromatography & Electrophoresis”, In: Contemporary Practice in Clinical Chemistry, 2nd Ed., W.Clarke and D.R. Dufour (Eds.), AACC Press: Washington, DC, 2011, Chap. 8.

2010

188.) Abby J. Jackson, Elizabeth M. Karle and David S. Hage*, “Preparation of High-Capacity Supports Containing Protein G Immobilized to Porous Silica”, Anal. Biochem., 406 (2010) 235-237.

187.) Hai Xuan, K.S. Joseph, Chunling Wa and David S. Hage*, “Biointeraction Analysis of Carbamazepine Binding to Alpha 1-Acid Glycoprotein by High-Performance Affinity Chromatography”, J. Sep. Sci., 33 (2010) 2294-2301.

186.) Abby J. Jackson, Hai Xuan and David S. Hage*, “Entrapment of Proteins in Glycogen-Capped and Hydrazide-Activated Supports”, Anal. Biochem., 404 (2010) 106-108.

185.) K. S. Joseph and David S. Hage*, “The Effects of Glycation on the Binding of Human Serum Albumin to Warfarin and L-Tryptophan”, J. Pharm. Biomed. Anal., 53 (2010) 811-818.

184.) Michelle J. Yoo, John S. Schiel and David S. Hage*, “Evaluation of Affinity Microcolumns containing Human Serum Albumin for Rapid Analysis of Drug-Protein Binding”, J. Chromatogr. B, 878 (2010) 1707-1713.

183.) K. S. Joseph and David S. Hage*, “Characterization of the Binding of Sulfonylurea Drugs to HSA by High-Performance Affinity Chromatography”, J. Chromatogr. B, 878 (2010) 1590-1598.

182.) Omar Barnaby, Chunling Wa, Ronald L. Cerny, William Clarke and David S. Hage*, “Quantitative Analysis of Human Serum Albumin using 16O/18O-Labeling and Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry”, Clin. Chim. Acta, 411 (2010) 1102-1110.

181.) David S. Hage*, Aptamers in Bioanalysis: Book Review”, Bioanalysis, 2 (2010) 719-720.

180.) Rangan Mallik, Michelle J. Yoo, Chad J. Briscoe and David S. Hage*, “Analysis of Drug-Protein Binding by Ultrafast Affinity Chromatography using Immobilized Human Serum Albumin”, J. Chromatogr. A, 1217 (2010) 2796-2803.

179.) Annette C. Moser and David S. Hage*, “Immunoaffinity Chromatography: An Introduction to Applications and Recent Developments”, Bioanalysis, 2 (2010) 769-790.

178.) Raychelle M. Burks and David S. Hage*, “Erratum: Current Trends in the Detection of Peroxide-Based Explosives”, Anal. Bioanal. Chem., 396 (2010) 3113-3114.

177.) S. Soman, Michelle J. Yoo, Yoon Jeong Jang and David S. Hage*, “Lidocaine Interactions with Serum Proteins Using High-Performance Affinity Chromatography”, J. Chromatogr. B, 878 (2010) 705-708.

176.) David S. Hage and James D. Carr, Solution Manual for Analytical Chemistry and Quantitative Analysis, Pearson/Prentice-Hall, 2010.

175.) David S. Hage and James D. Carr, Analytical Chemistry and Quantitative Analysis, Pearson/Prentice-Hall, 2010.

174.) David S. Hage, Frantisek Svec and Charles W. Gehrke, “Chromatography – Advances and Applications in Environmental, Space and Biological and Medical Sciences”, Chromatography: A Science of Discovery, C. W. Gehrke, R. L. Wixom and E. Bayer (eds.), Wiley, New York, Chapter 7.

173.) Michelle J. Yoo and David S. Hage*, “Affinity Monolith Chromatography: Principles and Recent Developments”, In: Monolithic Chromatography and Its Modern Applications, P. Wang (Editor), ILM Publications, UK.

172.) Mary Anne Nelson, Annette C. Moser and David S. Hage*, “Biointeraction Analysis by High-Performance Affinity Chromatography: Kinetic Studies of Immobilized Antibodies”, J. Chromatogr. B, 878 (2010) 165-171.

171.) Sike Chen, Matthew R. Sobansky and David S. Hage*, “Analysis of Drug Interactions with High-Density Lipoprotein by High-Performance Affinity Chromatography”, Anal. Biochem., 397 (2010) 107-114.

170.) David S. Hage*, “Weak Affinity Chromatography”, In: Encyclopedia of Chromatography, 3rd ed., J. Cazes (Editor), Taylor & Francis, New York, 2010.

169.) David S. Hage* and John E. Schiel, “Binding Constants: Determination by Affinity Chromatography”, In: Encyclopedia of Chromatography, 3rd ed., J. Cazes (Editor), Taylor & Francis, New York, 2010.

168.) David S. Hage*, “Immunoaffinity Chromatography”, In: Encyclopedia of Chromatography, 3rd ed., J. Cazes (Editor), Taylor & Francis, New York, 2010.

167.) David S. Hage*, “Affinity Chromatography: An Overview”, In: Encyclopedia of Chromatography, 3rd ed., J. Cazes (Editor), Taylor & Francis, New York, 2010.

2009
165.) John E. Schiel, K.S. Joseph and David S. Hage*, “Biointeraction Affinity Chromatography”, In: Advances in Chromatography, Vol. 48, N. Grinsberg and Eli Grushka (Editors), Taylor & Francis, New York, 2009, Chapter 4.164.) Raychelle M. Burks and David S. Hage*, “Current Trends in the Detection of Peroxide-Based Explosives”, Anal. Bioanal. Chem., 395 (2009) 301-313.163.) Michelle J. Yoo and David S. Hage*, “Evaluation of Silica Monoliths in Affinity Microcolumns for High-Throughput Analysis of Drug-Protein Interactions”, J. Sep. Sci., 32 (2009) 2776-2785.162.) Jianzhong Chen, John E. Schiel, and David S. Hage*, “Non-Competitive Peak Decay Analysis of Drug-Protein Dissociation by High-Performance Affinity Chromatography and Peak Profiling”, J. Sep. Sci., 32 (2009) 1632-1641.161.) John E. Schiel, Corey M. Ohnmacht and David S. Hage*, “Measurement of Drug-Protein Dissociation Rates by High-Performance Affinity Chromatography and Peak Profiling”, Anal. Chem., 81 (2009) 4320-4333.

160.) Michelle J. Yoo, Quentin R. Smith and David S. Hage*, “Studies of Imipramine Binding to Human Serum Albumin by High-Performance Affinity Chromatography”, J. Chromatogr. B, 877 (2009) 1149-1154.

159.) Mandi L. Conrad, Annette C. Moser and David S. Hage*, “Evaluation of Indole-Based Probes for Studying Drug Binding to Human Serum Albumin in High-Performance Affinity Separations”, J. Sep. Sci., 32 (2009) 1145-1155.

158.) John E. Schiel and David S. Hage*, “Kinetic Studies of Biological Interactions by Affinity Chromatography”, J. Sep. Sci., 32 (2009) 1507-1522.

157.) David S. Hage*, Abby Jackson, Matt Sobansky, John E. Schiel, Michelle J. Yoo, and K.S. Joseph, “Characterization of Drug-Protein Interactions in Blood using High-Performance Affinity Chromatography”, J. Sep. Sci., 32 (2009) 835-853.

156.) Chad J. Briscoe and David S. Hage*, “Factors Affecting the Stability of Drugs and Drug Metabolites in Biological Matrices”, Bioanalysis, 1 (2009) 205-220. (invited article – lead issue of journal)

155.) Raychelle M. Burks and David S. Hage*, “18-Crown-6 as a Class I Organic Modifier in Micellar Electrokinetic Chromatography”, Electrophoresis, 30 (2009) 657-660.

154.) K. S. Joseph, Annette C. Moser, Sara Basiaga, John E. Schiel and David S. Hage*, “Evaluation of Alternatives to Warfarin as Probes for Sudlow Site I of Human Serum Albumin: Characterization by High Performance Affinity Chromatography”, J. Chromatogr. A, 1216 (2009) 3492-3500.

153.) David S. Hage*, “Affinity Chromatography”, Handbook of HPLC, 2nd Edition, D. Corradini (ed.), Taylor & Francis/CRC Press, Boca Raton, FL, 2009, Chapter 4.

2008

153.) Chunling Wa, Rangan Mallik and David S. Hage*, “Development of Immunoaffinity Restricted Access Media for Rapid Extractions of Low Mass Analytes”, Anal. Chem., 80 (2008) 8751-8762.

152.) Rangan Mallik, Michelle J. Yoo, Sike Chen and David S. Hage*, “Studies of Verapamil Binding to Human Serum Albumin by High-Performance Affinity Chromatography”, J. Chromatogr. B, 876 (2008) 69-75.

151.) Matthew D. Shortridge, David S. Hage, Gerard S. Harbison and Robert Powers*, “Estimating Protein-Ligand Binding Affinity using High-Throughput Screening by NMR”, J. Combin. Chem., 10 (2008) 948-958.

150.) David H. Thomas, Jay D. Taylor, Omar S. Barnaby and David S. Hage*, “Determination of Free Catecholamines in Urine by Tandem Affinity/Ion-Pair Chromatography and Flow Injection Analysis”, Clin. Chim. Acta, 398 (2008) 63-69.

149.) Annette Moser and David S. Hage*, “Capillary Electrophoresis-Based Immunoassays: Principles & Quantitative Applications”, Electrophoresis, 29 (2008) 3279-3295.

137.) Rangan Mallik, Hai Xuan, Georges Guiochon and David S. Hage*,“Immobilization of α1-Acid Glycoprotein for Chromatographic Studies of Drug-Protein Binding. II. Correction for Errors in Association Constant Measurements”, Anal. Biochem., 376 (2008) 154-156.

136.) Rangan Mallik and David S. Hage*, “Development of an Affinity Silica Monolith Containing Human Serum Albumin for Chiral Separations”, J. Pharm. Biomed. Anal., 46 (2008) 820-830.

2007

135.) Chunling Wa, Ronald L. Cerny, William A. Clarke and David S. Hage*, “Characterization of Glycated Adducts on Human Serum Albumin by MALDI-TOF MS”, Clin. Chim. Acta, 385 (2007) 48-60. PMC2692699

134.) Chad J. Briscoe* Jeff D. Moran and David S. Hage, “System Suitability in Bioanalytical LC/MS/MS”, J. Pharm. Biomed. Anal., 44 (2007) 484-491.

133.) Rangan Mallik, Hai Xuan and David S. Hage*, “Development of an Affinity Silica Monolith Containing α1-Acid Glycoprotein for Chiral Separations”, J. Chromatogr. A, 1149 (2007) 294-304. PMC2043356

132.) Mary Anne Nelson, Efthimia Papastavros, Maud Dodlinger and David S. Hage*, “Environmental Analysis by On-Line Immunoextraction and Reversed-Phase Liquid Chromatography: Optimization of the Immunoextraction/RPLC Interface”, J. Agric. Food Chem, 55 (2007) 3788-3797.

131.) Annette Moser, Mary Anne Nelson and David S. Hage*, “Environmental Applications of Immunoaffinity Chromatography”, in: Immunoassay and Other Bioanalytical Techniques, J. Van Emon (Ed.), Marcel Dekker: New York, 2007.

130.) Chunling Wa, Rangan Mallik and David S. Hage*. “Development of Sulfhydryl-Reactive Silica for Protein Immobilization in High-Performance Affinity Chromatography” Analytical Chemistry  79(4) (2007) 1411-1424.

2006

116.) John E. Schiel and David S. Hage*, “Density Measurements of Potassium Phosphate Buffer from 4 to 45 C”, Talanta, 65 (2005) 495-500.

117.) David S. Hage*, “Affinity Chromatography”, Encyclopedia of Analytical Science, 2nd Ed., P. Worsfold, A. Townshend, C. Poole (eds.), Elsevier, 2005, pp. 190-197 (vol. 5).

118.) Chunling Wa, Ron L. Cerny and David S. Hage*. “Identification and Quantitative Studies of Protein Immobilization Sites by Stable Isotope Labeling and Mass Spectrometry”, Anal. Chem. 78(23) (2006) 7967-7977.

119.) Corey M. Ohnmacht, John E. Schiel and David S. Hage*. “Analysis of Free Drug Fractions Using Near-Infrared Fluorescent Labels and an Ultrafast Immunoextraction/Displacement Assay”, Anal. Chem. 78(21) (2006) 7547-7556.

120.) Rangan Mallik and David S. Hage*. ”Affinity monolith chromatography”, J. Sep. Sci. 29(12) (2006) 1686-1704.

121.) Hai Xuan and David S. Hage*. “Evaluation of a hydrazide-linked a 1-acid glycoprotein chiral stationary phase: separation of R- and S-propranolol”, J. Sep. Sci. 29 (2006) 1412-1422.

123.) Annette C. Moser, Charles Kingsbury and David S. Hage*. “Stability of warfarin solutions for drug-protein binding measurements: Spectroscopic and chromatographic studies”, J. Pharmaceut. Biomed. Anal. 41 (2006) 1101-1109.

124.) Hee Seung Kim , Rangan Mallik and David S. Hage*. “Chromatographic analysis of carbamazepine binding to human serum albumin”, J. Chromatogr. B 837 (2006) 138-146.

125.) Corey M. Ohnmacht, Shirley Chen , Zenghan Tong and David S. Hage*. “Studies by biointeraction chromatography of binding by phenytoin metabolites to human serum albumin”, J. Chromatogr. B 836 (2006) 83-91.

126.) John E. Schiel, Rangan Mallik, Sony Soman, Krina S. Joseph, and David S. Hage*. ”Applications of silica supports in affinity chromatography”, J. Sep. Sci. 29 (2006) 719-737.

127.) Jianzhong Chen and David S. Hage*. “Quantitative Studies of Allosteric Effects by Biointeraction Chromatography: Analysis of Protein Binding for Low-Solubility Drugs”, Anal. Chem. 78 (2006) 2672-2683.

128.) Chunling Wa, Ron Cerny and David S. Hage*. “Obtaining high sequence coverage in matrix-assisted laser desorption time-of-flight mass spectrometry for studies of protein modification: Analysis of human serum albumin as a model”, Anal. Biochem. 349 (2006) 229-241.

129.) Jianzhong Chen, Ilona Fitos and David S. Hage*. “Chromatographic analysis of allosteric effects between ibuprofen and benzodiazepines on human serum albumin”, Chirality 18 (2006) 24-36.

2005
101.) John E. Schiel and David S. Hage*, “Density Measurements of Potassium Phosphate Buffer from 4 to 45 C”, Talanta, 65 (2005) 495-500.102.) David S. Hage*, “Affinity Chromatography”, Encyclopedia of Analytical Science, 2nd Ed., P. Worsfold, A. Townshend, C. Poole (eds.), Elsevier, 2005, pp. 190-197 (vol. 5).103.) David S. Hage*, “Affinity Chromatography”, Kirk-Othmer Encyclopedia of Chemical Technology,Online Edition, Azra Seidel (ed.), Wiley, in press.104.) David S. Hage (Editor), Handbook of Affinity Chromatography, CRC Press/Taylor & Francis, 2005.105.) David S. Hage*, “Affinity Chromatography: An Overview”, In: Encyclopedia of Chromatography, 2nd ed., J. Cazes (Editor), Marcel Dekker, New York, 2005, pp. 33-39.

106.) David S. Hage*, “Immunoaffinity Chromatography”, In: Encyclopedia of Chromatography, 2nd ed., J. Cazes (Editor), Marcel Dekker, New York, 2005, pp. 822-827.

107.) David S. Hage*, “Binding Constants: Determination by Affinity Chromatography”, In: Encyclopedia of Chromatography, 2nd ed., J. Cazes (Editor), Marcel Dekker, New York, 2005, 184-190.

108.) Heeseung Kim and David S. Hage*, “Chromatographic Analysis of Carbamazepine Binding to Human Serum Albumin”, J. Chromatogr. B, 816 (2005) 57-66.

109.) Annette Moser, Mary Anne Nelson and David S. Hage*, “Environmental Applications of Immunoaffinity Chromatography”, in: Immunoassay and Other Bioanalytical Techniques, J. Van Emon (Ed.), Marcel Dekker: New York, in press.

110.) Tao Jiang, Rangan Mallik and David S. Hage*, “Affinity Monoliths for Ultrafast Immunoextraction”, Anal. Chem., 77 (2005) 2362-2372.

111.) William Clarke, John E. Schiel, Annette Moser and David S. Hage*, “Analysis of Free Hormone Fractions by an Ultrafast Immunoextraction/Displacement Immunoassay: Studies Using Free Thyroxine as a Model System”, Anal. Chem., 77 (2005) 1859-1866.

112.) David S. Hage* and Rangan Mallik, “Affinity Monoliths for Ultrafast Immunoextraction & Chiral Separations”, LabPlus Intl., 19 (2005) 6-9.

113.) Jianzhong Chen, Ilona Fitos and David S. Hage*, “Chromatographic Analysis of Allosteric Effects Between Ibuprofen and Benzodiazepines on Human Serum Albumin”, Chirality, in press.

114.) Hai Xuan and David S. Hage*, “Immobilization of “1-Acid Glycoprotein for Chromatographic Studies of Drug-Protein Binding”, Anal. Biochem., 346 (2005) 300-310.

115.) David S. Hage*, “Chromatography & Electrophoresis” In: Contemporary Practice in Clinical Chemistry, W.A. Clarke and D.R. Dufour (Eds.), AACC Press: Washington , DC , in press.

2000-2004
92.) David S. Hage*, “Weak Affinity Chromatography”, Dekker Encyclopedia of Chromatography, J. Cazes (ed.), Marcel Dekker, 2004, online article.93.) Hee Seung Kim, John Austin and David S. Hage*,”Screening Major Binding Sites on Human Serum Albumin by Affinity Capillary Electrophoresis”, Capillary Electrophoresis of Proteins and Peptides, M. A. Strege and A. L. Lagu (eds.), Humana Press, 2004, Chap. 9.94.) Jianzhong Chen, Corey M. Ohnmacht and David S. Hage*, “Characterization of Drug Interactions with Soluble Beta-Cyclodextrin by High-Performance Affinity Chromatography”, J. Chromatogr. A, 1033 (2004) 115-126.95.) Mary Anne Nelson, Arther Gates, Maud Dodlinger and David S. Hage*, “Development of a Portable Immunoextraction/RPLC System for Field Studies of Herbicide Residues”, Anal. Chem., 76 (2004) 805-813.96.) Hee Seung Kim, Young Sik Kye and David S. Hage*,”Development & Evaluation of N-Hydroxysuccinimide-Activated Silica for Immobilization of Human Serum Albumin in HPLC Columns”, J. Chromatogr. A, 1049 (2004) 51-61.97.) Jianzhong Chen, Corey Ohnmacht and David S. Hage*,”Studies of Phenytoin Binding to Human Serum Albumin by High-Performance Affinity Chromatography” J. Chromatogr. B, 809 (2004) 137-145.

98.) Jianzhong Chen and David S. Hage*,”Quantitative Analysis of Allosteric Drug-Protein Binding by Biointeraction Chromatography”, Nature Biotechnol., 22 (2004) 1445-1448.

99.) David S. Hage* and Arundhati Sengupta, “Correction: Studies of Protein Binding to Non-Polar Solutes by using Zonal Elution and High-Performance Affinity Chromatography: Interactions of cis- and trans-Clomiphene with Human Serum Albumin in the Presence of Beta-Cyclodextrin”, Anal. Chem., 76 (2004) 5982.

100.) Rangan Mallik, Tao Jiang and David S. Hage*,”High-Performance Affinity Monolith Chromatography: Development & Evaluation of Human Serum Albumin Columns”, Anal. Chem., 76 (2004) 7013-7022.

86.) Mary Anne Nelson, Wanda S. Reiter and David S. Hage*,”Chromatographic Competitive Binding Immunoassays: A Comparison of the Sequential and Simultaneous Injection Methods”, Biomed. Chromatogr., 17 (2003) 188-200.

87.) David S. Hage,”Clinical Applications of Affinity Chromatography”, Advances in Chromatography, vol. 42, P. R. Brown and H. Isaaq, Editors, Marcel Dekker, Chap. 8, 2003.

88.) William Clarke and David S. Hage*, “Clinical Applications of Affinity Chromatography”, Separation Techniques in Clinical Chemistry, H. Y. Aboul-Enein, Editor, Marcel Dekker, 2003.

89.) David S. Hage* and William Clarke, “Immunoaffinity Chromatography in Clinical Analysis”, Separation Techniques in Clinical Chemistry, H. Y. Aboul-Enein, Editor, Marcel Dekker, 2003.

90.) William Clarke and David S. Hage*, “Clinical Applications of Affinity Chromatography”, Separation and Purification Reviews, 32 (2003) 19-60.

91.) David S. Hage*, “Using Periodate with Nitrite Solutions for Capillary Electrophoresis”, J. Chem. Educ. 80 (2003) 1138.

83.) David S. Hage*, “High-Performance Affinity Chromatography: A Powerful Tool for Studying Serum Protein Binding”, J. Chromatogr. B, 768 (2002) 3-30.

84.) Hee Seung Kim, John Austin and David S. Hage*, “Identification of Drug-Binding Sites on Human Serum Albumin using Affinity Capillary Electrophoresis and Chemically Modified Proteins as Buffer Additives”, Electrophoresis, 23 (2002) 956-963.

85.) Matthew R. Oates, William Clarke, Alden Zimlich II and David S. Hage*, “Optimization and Development of an HPLC-Based One-Site Immunometric Assay with Chemiluminescence Detection”, Anal. Chim. Acta, 470 (2002) 37-50.

76.) David S. Hage*, “Chromatographic and Electrophoretic Studies of Protein Binding to Chiral Solutes”, J. Chromatogr. B, 906 (2001) 459.

77.) David S. Hage* and Mary Anne Nelson, “Chromatographic Immunoassays”, Anal. Chem., 73 (2001) 198A-205A.

78.) William Clarke and David S. Hage*, “Development of Sandwich HPLC Microcolumns for Millisecond Extractions of Analytes”, Anal. Chem., 73 (2001) 1366-1373.

79.) William Clarke, A. Roy Choudhuri and David S. Hage*, “Analysis of Free Drug Fractions by Ultra-fast Immunoaffinity Chromatography”, Anal. Chem., 73 (2001) 2157-2164.

80.) David S. Hage* and William Clarke, “Affinity Chromatography: An Overview”, In: Encyclopedia of Chromatography, J. Cazes (Editor), Marcel Dekker, New York , 2001, Chap. 8.

81.) David S. Hage* and John Austin, “Immunoaffinity Chromatography”, In: Encyclopedia of Chromatography, J. Cazes (Editor), Marcel Dekker, New York , 2001, Chap. 151.

82.) David S. Hage* and Sanjay Mukherjee, “Binding Constants: Determination by Affinity Chromatography”, In: Encyclopedia of Chromatography, J. Cazes (Editor), Marcel Dekker, New York , 2001, Chap. 27.

70.) David S. Hage*, “Periodate Oxidation of Antibodies for Site-Selective Immobilization in Immunoaffinity Chromatography”, In: Affinity Chromatography: Methods and Protocols, P. Bailon, G. W. Ehrlich, W.-J. Fung and W. Berthold (Eds.), Humana Press, Totowa , NJ ; 2000, Chapter 7.

71.) David S. Hage* and John Austin, “High-Performance Affinity Chromatography and Immobilized Serum Albumin as Probes for Drug- and Hormone-Protein Binding”, J. Chromatogr. B, 739 (2000) 39-54.

72.) David S. Hage*, “Affinity Chromatography”, In: Encyclopedia of Analytical Chemistry: Instrumentation and Applications, R. A. Meyers (Editor-in-chief), Wiley, New York ; 2000.

73.) Jennifer L. Brocky and David S. Hage*, “Separation of Near-Infrared Fluorescent Conjugates of dATP and Related Compounds by Capillary Electrophoresis”, J. Chromatogr. B, 744 (2000) 315-321.

74.) William Clarke, Julie D. Beckwith, Amiee Jackson, Bambi Reynolds, Elizabeth M. Karle and David S. Hage*, “Antibody Immobilization to High-Performance Liquid Chromatographic Supports: Characterization of Maximum Loading Capacity for Intact Immunoglobulin G and Fab Fragments”, J. Chromatogr. A, 888 (2000) 13-22.

75.) John Kenkel*, Paul B. Kelter and David S. Hage, Chemistry: An Industry-Based Introduction, CRC Press, Boca Raton , FL ; 2000.

1995-199928.) John Rollag, Tsentao Liu and David S. Hage*, “Analysis of MHPG in Urine using Tandem Reversed-Phase Liquid Chromatography with Electrochemical Detection”, J. Chromatogr. B, 663 (1995) 193-200.29.) K. Machele Miller and David S. Hage*, “Survey of Long Term Integrated Laboratory Use in Undergraduate Chemistry Programs”, J. Chem. Educ., 72 (1995) 248-250.

30.) David S. Hage*, Terence A. G. Noctor and Irving W. Wainer, “Characterization of the Protein Binding of Chiral Drugs by High-Performance Affinity Chromatography: Interactions of R- and S-Ibuprofen with Human Serum Albumin”, J. Chromatogr. A, 693 (1995) 23-32.

31.) Bounthon Loun and David S. Hage*, “Characterization of Thyroxine-Albumin Binding using High-Performance Affinity Chromatography. II. Comparison of the Binding of Thyroxine, Triiodothyronines and Related Compounds at the Warfarin and Indole Sites of Human Serum Albumin”, J. Chromatogr. B, 665 (1995) 303-314.

32.) David S. Hage*, “Immunoassays”, Anal. Chem., 67 (1995) 455R-462R.

33.) Carrie A. C. Wolfe and David S. Hage*, “Studies on the Rate and Control of Antibody Oxidation by Periodate”, Anal. Biochem., 231 (1995) 123-130.

34.) David S. Hage*, “Gas Chromatography”, In: Principles of Laboratory Methods, M. Haven (Ed.). Van Nostrand Reinhold: New York ; 1995, Chap. 15.

35.) Bounthon Loun and David S. Hage*, “Chiral Separation Mechanisms in Protein-Based HPLC Columns. II. Kinetic Studies of R- and S-Warfarin Binding to Immobilized Human Serum Albumin”, Anal. Chem., 68 (1996) 1218-1225.

36.) Ju Yang, Sahana Roy Choudhuri and David S. Hage*, “Improved Reproducibility in Capillary Electrophoresis through the use of Mobility and Migration Time Ratios”, J. Chromatogr. A, 725 (1996) 273-285.

37.) Ju Yang and David S. Hage*, “Role of Binding Capacity versus Binding Strength in the Separation of Chiral Compounds by Protein-Based HPLC Columns”, J. Chromatogr. A, 725 (1996) 273-285.

38.) Wanda S. Reiter and David S. Hage*, “Optimization of HPLC Detection for Acridinium Ester-Labeled Antibodies”, J. Clin. Ligand Assay, 19 (1996) 246-252.

39.) Jasbir Singh, Tian C. Zhang*, Patrick J. Shea, Steven D. Comfort, Lakhwinder S. Hundal and David S. Hage, “Transformation of Atrazine and Nitrate in Contaminated Water by Iron Promoted Processes”, Proceedings of WEFTEC’96, Vol. 3, Part 1: Remediation of Soil and Groundwater, Water Environment Federation, Alexandria, VA, 1996, pp. 143-150.

40.) John G. Rollag, Melissa Beck-Westermeyer and David S. Hage*, “Analysis of Pesticide Degradation Products by Tandem High-Performance Immunoaffinity Chromatography and Reversed-Phase Liquid Chromatography”, Anal. Chem., 68 (1996) 3631-3637.4

1.) John G. Rollag, Tsentao Liu and David S. Hage*, “Optimization of Post-Column Chemiluminescent Detection for Low-Molecular Mass Conjugates of Acridinium Esters”, J. Chromatogr. A, 765 (1997) 145-155.

42.) Anuja Chattopadhyay and David S. Hage*, “Determination of the Diol Content of Chromatographic Supports by Capillary Electrophoresis”, J. Chromatogr. A, 758 (1997) 255-261.

43.) Ju Yang and David S. Hage*, “Effect of Mobile Phase Composition on the Binding Kinetics of Chiral Solutes on a Protein-Based HPLC Column: Interactions of D- and L-tryptophan with Immobilized Human Serum Albumin”, J. Chromatogr. A, 766 (1997) 15-25.

44.) David S. Hage*, “Immunoassays”, Anal. Chem., 69 (1997) 165R-171R, 214R-218R.

45.) David S. Hage*, John G. Rollag and David H. Thomas, “Analysis of Atrazine and its Degradation Products in Water by Tandem High-Performance Immunoaffinity Chromatography and Reversed-Phase Liquid Chromatography”, In: Immunochemical Technology for Environmental Applications, D. S. Aga and E. M. Thurman (Eds.). ACS Press, Washington , DC ; 1997, Chap. 10.

46.) Sahana Bose, Ju Yang and David S. Hage*, “Guidelines in Selecting Ligand Concentrations for the Determination of Binding Constants by Affinity Capillary Electrophoresis”, J. Chromatogr. B, 697 (1997) 77-88.

47.) David S. Hage*, “Chiral Separations in Capillary Electrophoresis using Proteins as Stereoselective Binding Agents”, Electrophoresis, 18 (1997) 2311-2321.

48.) David S. Hage* and Stacey A. Tweed, “Recent Advances in Chromatographic and Electrophoretic Methods for the Study of Drug-Protein Interactions”, J. Chromatogr. B, 699 (1997) 499-528.

49.) Paul B. Kelter*, Julie Grundman, David S. Hage and James D. Carr, “A Discussion of Water Pollution in the United States and Mexico with a Focus on High School Laboratory Activities for the Analysis of Lead, Atrazine and Nitrate, J. Chem. Educ., 74 (1997) 1413-1421.

50.) David S. Hage*, “Principles and Practice of Immunoassay” (Book Review), Trends Biotechnol., 15 (1997) 480-481.

51.) David S. Hage*, Carrie A. C. Wolfe and Matthew R. Oates, “Development of a Kinetic Model to Describe the Effective Rate of Antibody Oxidation by Periodate”, Bioconj. Chem., 8 (1997) 914-920.

52.) Stacey A. Tweed, Bounthon Loun and David S. Hage*, “Effects of Ligand Heterogeneity in the Characterization of Affinity Columns by Frontal Analysis”, Anal. Chem., 69 (1997) 4790-4798.

53.) David S. Hage*, “Chromatographic Approaches to Immunoassays”, J. Clin. Ligand Assay, 20 (1997) 293-301.

54.) John G. Rollag and David S. Hage*, “Non-Linear Elution Effects in Split-Peak Chromatography. 2. Role of Ligand Heterogeneity in Solute Binding to Columns with Adsorption-Limited Kinetics”, J. Chromatogr. A, 795 (1998) 185-198.

55.) Carrie A. C. Wolfe, Matthew R. Oates and David S. Hage*, “Automated Protein Assay using Flow Injection Analysis”, J. Chem. Educ., 75 (1998) 1025-1028.

56.) David S. Hage*, “Affinity Chromatography”, In: Handbook of HPLC, E. Katz, R. Eksteen, P. Schoenmakers and N. Miller (Eds.). Marcel Dekker, New York ; 1998, Chap. 13.

57.) Matthew R. Oates, William C. Clarke and David S. Hage*, “Kinetic Studies on the Immobilization of Antibodies to High-Performance Liquid Chromatographic Supports”, Bioconj. Chem., 9 (1998) 459-465.

58.) David S. Hage*, “A Survey of Recent Advances in Analytical Applications of Immunoaffinity Chromatography”, J. Chromatogr. B, 715 (1998) 3-28.

59.) Anuja Chattopadhyay, Tong Tian, Laurie Kortum and David S. Hage*, “Development of Tryptophan-Modified Human Serum Albumin Columns for Site-Specific Studies of Drug-Protein Interactions by High-Performance Affinity Chromatography, J. Chromatogr. B, 715 (1998) 183-190.

60.) David S. Hage* and Arundhati Sengupta, “Studies of Protein Binding to Non-Polar Solutes by using Zonal Elution and High-Performance Affinity Chromatography: Interactions of cis- and trans-Clomiphene with Human Serum Albumin in the Presence of Beta-Cyclodextrin”, Anal. Chem., 70 (1998) 4602-4609.

61.) Jasbir Singh, Patrick J. Shea*, Lakhwinder S. Hundal, Steve D. Comfort, Tian C. Zhang and David S. Hage, “Iron-Enhanced Remediation of Water and Soil Containing Atrazine”, Weed Science, 49 (1998) 381-390.

62.) David S. Hage*, Anuja Chattopadhyay, Carrie A. C. Wolfe, Julie Grundman and Paul B. Kelter, “Determination of Nitrate and Nitrite in Water by Capillary Electrophoresis”, J. Chem. Educ., 75 (1998) 1588-1590.

63.) Jeffrey M. Ashley, Bruce I. Dvorak*, David S. Hage and Matthew Oates, “Activated Carbon Treatment of s-Triazines and Their Metabolites”, Proc. ASCE Environ. Eng. Conf.; Amer. Soc. Civil Engin. , Washington DC; 1998, pp. 338-343.

64.) Arundhati Sengupta and David S. Hage*, “Characterization of the Binding of Digitoxin and Acetyldigitoxin to Human Serum Albumin by High-Performance Affinity Chromatography”, J. Chromatogr. B., 725 (1999) 91-100.

65.) David S. Hage*, “Immunoassays”, Anal. Chem., 71 (1999) 294R-304R.

66.) David S. Hage*, David H. Thomas, A. Roy Chowdhuri and William Clarke, “Development of a Theoretical Model for Chromatographic-Based Competitive Binding Immunoassays with Simultaneous Injection of Sample and Label”, Anal. Chem., 71 (1999) 2965-2975.

67.) David S. Hage*, “Affinity Chromatography: A Review of Clinical Applications”, Clin. Chem., 45 (1999) 593-615.

68.) Jeffrey M. Ashley, Bruce I. Dvorak* and David S. Hage, “GAC and PAC Systems Analysis: Implications of the Regulation of s-Triazine Metabolites”, Amer. Water Works Assoc. Ann. Conf., Amer. Water Works Assoc., Washington DC; 1999, p. W-16-5.

69.) Arundhati Sengupta and David S. Hage*, “Characterization of Minor Site Probes for Human Serum Albumin by High-Performance Affinity Chromatography”, Anal. Chem., 71 (1999) 3821-3827.

1984-19941.) David S. Hage* and Rodney R. Walters, “Non-linear elution effects in split-peak chromatography. I. Computer simulations for the cases of irreversible diffusion- and adsorption-limited kinetics”, J. Chromatogr., 436(2) (1988) 111-35.2.) David S. Hage*, “Split-peak determination of protein adsorption kinetics in high-performance affinity chromatography”’ Diss. Abstr. Int. B 48(4) (1987) 1025-6.

3.) David S. Hage* and Rodney R. Walters, “Dual-column determination of albumin and immunoglobulin G in serum by high-performance affinity chromatography” , J. Chromatogr., 386 (1987) 37-49.

4.) David S. Hage*, Rodney R. Walters and Herbert W. Hethcote, “Split-peak affinity chromatographic studies of the immobilization-dependent adsorption kinetics of protein A, Anal. Chem. 58(2) (1986) 274-9.

5.) David S. Hage* and Paul J. Taylor, “Spectroscopy interfacing package. Part 1: Spectrum recorder”, Computer Applications in the Lab. 2(2) (1984) 100-8.

6.) David S. Hage* and Paul J. Taylor, “Spectroscopy interfacing package. Part II: Spectrum Worker”, Computer Applications in the Lab. 2(4) (1984) 226-33.

7.) David S. Hage* and Paul J. Taylor, “Spectroscopy interfacing package. Part 3: spectrum plotter”, Computer Applications in the Lab. 2(5) (1984) 326-31.

8.) David S. Hage*, Bob Taylor, Pat Schryver and Pai C. Kao, “Use of Affinity Chromatography in Developing Acridinium Ester-labeled Antibodies for an Immunometric Assay of Parathyrin”, Clin. Chem., 37 (1991) 117-118.

9.) David S. Hage* and Pai C. Kao, “High-Performance Immunoaffinity Chromatography and Chemiluminescence in the Automation of a Parathyroid Hormone Sandwich Immunoassay”, Anal. Chem., 63 (1991) 586-595.

10.) David S. Hage*, “Immunoassays”, Anal. Chem., 63 (1991) 206R-209R.

11.) David S. Hage*, Robert L. Taylor and Pai C. Kao, “Improved Recovery of a Radiolabeled Peptide with an Albumin-treated Reversed-phase HPLC Column”, Clin. Chem., 38 (1992) 303-304.

12.) David S. Hage*, Bob Taylor and Pai C. Kao, “Intact Parathyroid Hormone: Performance and Clinical Utility of an Automated Assay Based on High-Performance Immunoaffinity Chromatography and Chemiluminescent Detection”, Clin. Chem., 38 (1992) 1494-1500.

13.) Terence A. G. Noctor*, Irving W. Wainer and David S. Hage, “Allosteric and Competitive Displacement of Drugs from Human Serum Albumin by Octanoic Acid, as Revealed by High-Performance Liquid Affinity Chromatography on a Human Serum Albumin-Based Stationary Phase”, J. Chromatogr., 579 (1992) 305-315.

14.) Bounthon Loun and David S. Hage*, “Characterization of Thyroxine-Albumin Binding using High-Performance Affinity Chromatography”, J. Chromatogr., 579 (1992) 225-235.

15.) David S. Hage*, David H. Thomas and Melissa S. Beck, “Theory of a Sequential Addition Competitive Binding Immunoassay Based on High-Performance Immunoaffinity Chromatography”, Anal. Chem., 65 (1993) 1622-1630.

16.) Ju Yang and David S. Hage*, “Characterization of the Binding and Chiral Separation of D- and L-Tryptophan on a High-Performance Immobilized Human Serum Albumin Column”, J. Chromatogr., 645 (1993) 241-250.

17.) David S. Hage*, “Immunoassays”, Anal. Chem., 65 (1993) 420R-424R.

18.) David S. Hage*, “Chromatography”, In: Principles of Laboratory Instruments, L. Schoeff and R. H. Williams (Eds.). Mosby: St. Louis , MO; 1993.

19.) David S. Hage*, “Chemiluminescent Detection in High-Performance Liquid Chromatography”, In: HPLC Detection – Newer Methods, G. Patonay (Ed.). VCH: New York; 1993.

20.) Peggy F. Ruhn, Susan Garver and David S. Hage*, “Development of Dihydrazide-Activated Silica Supports for High-Performance Affinity Chromatography”, J. Chromatogr. A, 669 (1994) 9-19.

21.) Charles Keener, Carrie A. C. Wolfe and David S. Hage*, “Optimization of Oxidized Antibody Labeling with Lucifer Yellow CH”, Biotechniques, 16 (1994) 894-897.

22.) Carrie A. C. Wolfe and David S. Hage*, “Automated Determination of Antibody Oxidation using Flow Injection Analysis”, Anal. Biochem., 219 (1994) 26-31.

23.) Ju Yang, X.-Z. Wang, David S. Hage*, Patricia L. Herman, and Donald P. Weeks, “Analysis of Dicamba Degradation by Pseudomonas maltophilia using High-Performance Capillary Electrophoresis”, Anal. Biochem., 219 (1994) 37-42.

24.) Ju Yang and David S. Hage*, “Chiral Separations in Capillary Electrophoresis using Human Serum Albumin as a Buffer Additive”, Anal. Chem., 66 (1994) 2719-2725.

25.) David H. Thomas, Melissa Beck-Westermeyer and David S. Hage*, “Determination of Atrazine in Water using High-Performance Immunoaffinity Chromatography and Reversed-Phase Liquid Chromatography”, Anal. Chem., 66 (1994) 3823-3829.

26.) Bounthon Loun and David S. Hage*, “Chiral Separation Mechanisms in Protein-Based HPLC Columns. I. Thermodynamic Studies of R- and S-Warfarin Binding to Immobilized Human Serum Albumin”, Anal. Chem., 66 (1994) 3814-3822.

27.) Peggy F. Ruhn, J. D. Taylor and David S. Hage*, “Determination of Urinary Albumin using High-Performance Immunoaffinity Chromatography and Flow Injection Analysis”, Anal. Chem., 66 (1994) 4265-4271.

Books and Chapters

  1. David S. Hage* and Peggy F. Ruhn, “An Introduction to Affinity Chromatography”, In: Handbook of Affinity Chromatography, (D. S. Hage, Editor), CRC Press/Taylor & Francis, 2005, Chapter 1.
  2. Hee Seung Kim and David S. Hage*, “Immobilization Methods for Affinity Chromatography”, In: Handbook of Affinity Chromatography, (D. S. Hage, Editor), CRC Press/Taylor & Francis, 2005, Chapter 3.
  3. David S. Hage*, Hai Xuan and Mary Anne Nelson, “Application & Elution in Affinity Chromatography”, In: Handbook of Affinity Chromatography, (D. S. Hage, Editor), CRC Press/Taylor & Francis, 2005, Chapter 4.
  4. David S. Hage*, Min Bian, Raychelle Burks, Elizabeth Karle, Corey Ohnmacht and Chunling Wa , “Bioaffinity Chromatography”, In: Handbook of Affinity Chromatography, (D. S. Hage, Editor), CRC Press/Taylor & Francis, 2005, Chapter 5.
  5. David S. Hage* and Terry M. Phillips, “Immunoaffinity Chromatography”, In: Handbook of Affinity Chromatography, (D. S. Hage, Editor), CRC Press/Taylor & Francis, 2005, Chapter 6.
  6. Carrie A. C. Wolfe, William Clarke and David S. Hage*, “Affinity Methods in Clinical & Pharmaceutical Analysis”, In: Handbook of Affinity Chromatography, (D. S. Hage, Editor), CRC Press/Taylor & Francis, 2005, Chapter 17.
  7. Mary Anne Nelson and David S. Hage*, “Environmental Analysis by Affinity Chromatography”, In: Handbook of Affinity Chromatography, (D. S. Hage, Editor), CRC Press/Taylor & Francis, 2005, Chapter 19.
  8. David S. Hage* and Jianzhong Chen, “Quantitative Affinity Chromatography: Practical Aspects”, In: Handbook of Affinity Chromatography, (D. S. Hage, Editor), CRC Press/Taylor & Francis, 2005, Chapter 22.
  9. Chad J. Briscoe, William Clarke and David S. Hage*, “Affinity Mass Spectrometry”, In: Handbook of Affinity Chromatography, (D. S. Hage, Editor), CRC Press/Taylor & Francis, 2005, Chapter 27.
  10. Annette C. Moser and David S. Hage*, “Chromatographic Immunoassays”, In: Handbook of Affinity Chromatography, (D. S. Hage, Editor), CRC Press/Taylor & Francis, 2005, Chapter 29.